Behind the Study: Inhibition of Resistant Triple-negative Breast Cancer Cells
September 19, 2022
Dr. Balraj Singh from the University of Texas MD Anderson Cancer Center, describes a recent research paper he co-authored that was published by Oncotarget, entitled, “Inhibition of resistant triple-negative breast... read more